Thiol-based redox metabolism of protozoan parasites

被引:183
作者
Müller, S
Liebau, E
Walter, RD
Krauth-Siegel, RL
机构
[1] Heidelberg Univ, Ctr Biochem, D-69120 Heidelberg, Germany
[2] Univ Dundee, Sch Life Sci, Div Biol Chem & Mol Microbiol, Dundee DD1 5EH, Scotland
[3] Bernhard Nocht Inst Trop Med, Dept Biochem, D-20359 Hamburg, Germany
关键词
D O I
10.1016/S1471-4922(03)00141-7
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The review considers redox enzymes of Plasmodium spp., Trypanosomatida, Trichomonas, Entamoeba and Giardia, with special emphasis on their potential use as targets for drug development. Thiol-based redox systems play pivotal roles in the success and survival of these parasitic protozoa. The synthesis of cysteine, the key molecule of any thiol metabolism, has been elucidated in trypanosomatids and anaerobes. In trypanosomatids, trypanothione replaces the more common glutathione system. The enzymes of trypanothione synthesis have recently been identified. The role of trypanothione in the detoxification of reactive oxygen species is reflected in the multiplicity of trypanothione-dependent peroxidases. In Plasmodium falciparum, the crystal structures of glutathione reductase and glutamate dehydrogenase are now available; another drug target, thioredoxin reductase, has been demonstrated to be essential for the malarial parasite.
引用
收藏
页码:320 / 328
页数:9
相关论文
共 69 条
[1]   Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 2: Substitution of the glycine part [J].
Amssoms, K ;
Oza, SL ;
Augustyns, K ;
Yamani, A ;
Lambeir, AM ;
Bal, G ;
Van der Veken, P ;
Fairlamb, AH ;
Haemers, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (19) :2703-2705
[2]   Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents [J].
Augustyns, K ;
Amssoms, K ;
Yamani, A ;
Rajan, PK ;
Haemers, A .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (12) :1117-1141
[3]   Design, synthesis, and biochemical evaluation of phosphonate and phosphonamidate analogs of glutathionylspermidine as inhibitors of glutathionylspermidine synthetase/amidase from Escherichia coli [J].
Chen, SJ ;
Lin, CH ;
Kwon, DS ;
Walsh, CT ;
Coward, JK .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (23) :3842-3850
[4]   Trifluoromethionine, a prodrug designed against methionine γ-lyase-containing pathogens, has efficacy in vitro and in vivo against Trichomonas vaginalis [J].
Coombs, GH ;
Mottram, JC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) :1743-1745
[5]   A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline [J].
Davioud-Charvet, E ;
Delarue, S ;
Biot, C ;
Schwöbel, B ;
Boehme, CC ;
Müssigbrodt, A ;
Maes, L ;
Sergheraert, C ;
Grellier, P ;
Schirmer, RH ;
Becker, K .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4268-4276
[6]  
Davioud-Charvet E., 2002, FLAVINS FLAVOPROTEIN, P845
[7]   Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages [J].
Dumas, C ;
Ouellette, M ;
Tovar, J ;
Cunningham, ML ;
Fairlamb, AH ;
Tamar, S ;
Olivier, M ;
Papadopoulou, B .
EMBO JOURNAL, 1997, 16 (10) :2590-2598
[8]   ANTIOXIDANT DEFENSES IN THE MICROAEROPHILIC PROTOZOAN TRICHOMONAS-VAGINALIS - COMPARISON OF METRONIDAZOLE-RESISTANT AND SENSITIVE STRAINS [J].
ELLIS, JE ;
YARLETT, N ;
COLE, D ;
HUMPHREYS, MJ ;
LLOYD, D .
MICROBIOLOGY-SGM, 1994, 140 :2489-2494
[9]  
FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695
[10]   TRYPANOTHIONE - A NOVEL BIS(GLUTATHIONYL)SPERMIDINE COFACTOR FOR GLUTATHIONE-REDUCTASE IN TRYPANOSOMATIDS [J].
FAIRLAMB, AH ;
BLACKBURN, P ;
ULRICH, P ;
CHAIT, BT ;
CERAMI, A .
SCIENCE, 1985, 227 (4693) :1485-1487